Neonatal Abstinence Syndrome (NAS): Understanding the Impact and Promoting Effective Management

Author(s): Pfueller Caspar

Neonatal Abstinence Syndrome (NAS) is a complex and growing public health concern that affects infants exposed to substances, particularly opioids, during pregnancy. NAS occurs when infants experience withdrawal symptoms as a result of discontinuation of drug exposure after birth. This article aims to provide a comprehensive understanding of NAS, including its causes, symptoms, risk factors, and effective management strategies, with the ultimate goal of improving outcomes for affected infants and their families.